Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recall of type specific antibodies in man by injections of streptococcal cell walls.

Literature DB >> 14488286

Recall of type specific antibodies in man by injections of streptococcal cell walls.

E V POTTER, G H STOLLERMAN, A C SIEGEL.

Abstract

Entities: Species

Keywords: ANTIBODIES; STREPTOCOCCUS/immunology

Mesh：

Substances：
Antibodies

Year: 1962 PMID： 14488286 PMCID： PMC289227 DOI： 10.1172/JCI104483

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

19 in total

1. Thermolabile factors in human plasma that promote phagocytosis of virulent group A streptococci.

Authors: G H STOLLERMAN
Journal: Trans Assoc Am Physicians Date: 1961

2. Type-specific antibody formation in man following injection of streptococcal M protein.

Authors: W C SCHMIDT
Journal: J Infect Dis Date: 1960 May-Jun Impact factor: 5.226

3. Type-specific streptococcal antibody.

Authors: F W DENNY; W D PERRY; L W WANNAMAKER
Journal: J Clin Invest Date: 1957-07 Impact factor: 14.808

4. Studies of streptococcal cell walls. II. Type-specific antigenicity in rabbits.

Authors: S S BARKULIS; G WALSH; R D EKSTEDT
Journal: J Bacteriol Date: 1958-07 Impact factor: 3.490

5. Studies on immunity to streptococcal infections in man.

Authors: L W WANNAMAKER; F W DENNY; W D PERRY; A C SIEGEL; C H RAMMELKAMP
Journal: AMA Am J Dis Child Date: 1953-09

6. Streptococcal bacteriostatic antibody in patients treated with penicillin.

Authors: G DAIKOS; L WEINSTEIN
Journal: Proc Soc Exp Biol Med Date: 1951-10

7. Persistence of type-specific antibodies in man following infection with group A streptococci.

Authors: R C LANCEFIELD
Journal: J Exp Med Date: 1959-08-01 Impact factor: 14.307

8. Factors affecting the chain length of group A streptococci. II. Quantative M-anti-M relationships in the long chain test.

Authors: R D EKSTEDT; G H STOLLERMAN
Journal: J Exp Med Date: 1960-10-01 Impact factor: 14.307

9. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods.

Authors: G H STOLLERMAN; F S KANTOR; B D GORDON
Journal: J Exp Med Date: 1958-10-01 Impact factor: 14.307

10. Evaluation of the "long chain reaction" as a means for detecting type-specific antibody to group a streptococci in human sera.

Authors: G H STOLLERMAN; A C SIEGEL; E E JOHNSON
Journal: J Exp Med Date: 1959-12-01 Impact factor: 14.307

10 in total

1. Vaccination against rheumatic heart disease: a review of current research strategies and challenges.

Authors: Manisha Pandey; Michael R Batzloff; Michael F Good
Journal: Curr Infect Dis Rep Date: 2012-08 Impact factor: 3.725

Review 2. M proteins of group A streptococci.

Authors: E N Fox
Journal: Bacteriol Rev Date: 1974-03

3. Secondary and apparent primary antibody responses after group A streptococcal vaccination of 21 children.

Authors: B F Massell; J G Michael; J Amezcua; M Siner
Journal: Appl Microbiol Date: 1968-03

4. Protective immunity to the group A Streptococcus may be only strain specific.

Authors: S A de Malmanche; D R Martin
Journal: Med Microbiol Immunol Date: 1994-12 Impact factor: 3.402

5. Streptococcal neuraminidase and acute glomerulonephritis.

Authors: E V Potter; M A Shaughnessy; T Poon-King; D P Earle
Journal: Infect Immun Date: 1982-12 Impact factor: 3.441

6. Serum immunoglobulin A and antibody to M-associated protein in patients with acute glomerulonephritis or rheumatic fever.

Authors: E V Potter; M A Shaughnessy; T Poon-King; D P Earle
Journal: Infect Immun Date: 1982-07 Impact factor: 3.441

10. Antigenicity of the M proteins of group A hemolytic streptococci. 3. Antibody responses and cutaneous hypersensitivity in humans.

Authors: E N Fox; M K Wittner; A Dorfman
Journal: J Exp Med Date: 1966-12-01 Impact factor: 14.307